Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
Objective: To evaluate the cost-effectiveness of bedaquiline plus background drug regimens (BR) for multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) in Italy. Methods: A Markov model was adapted to the Italian setting to estimate the incremental cost-eff...
Gardado en:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2017-01-01
|
| Series: | Journal of Market Access & Health Policy |
| Assuntos: | |
| Acceso en liña: | http://dx.doi.org/10.1080/20016689.2017.1283105 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
